switching from wegovy to tirzepatide between weight-loss medications Wegovy Outperforms Tirzepatide in Reducing

However, newer studies are revealing that the gastrointestinal issues linked to these drugs may not just be short-term

Nausea was found to be the most frequent side effect, followed by vomiting, injection site issues, constipation, pancreatitis, and gastroparesis

This article examines the potential mechanisms, what to monitor, and when to seek medical advice regarding menstrual changes whilst taking Rybelsus

Mavroson urges patients to have an open discussion with their provider about any potential serious risks or side effects that could occur while using a GLP-1

Discontinue tirzepatide when the patient is pregnant

This study shows that -MSH is expressed in the heart and it protects against pathological cardiac remodeling by activating MC5-R in cardiomyocytes